Nobilis E.coli inac ενέσιμο γαλάκτωμα για όρνιθες
Nobilis E.coli inac ενέσιμο γαλάκτωμα για όρνιθες
Authorised
- Escherichia coli, flagellar toxin
- Escherichia coli, fimbrial adhesin F11
Product identification
Medicine name:
Nobilis E.coli inac ενέσιμο γαλάκτωμα για όρνιθες
Active substance:
- Escherichia coli, flagellar toxin
- Escherichia coli, fimbrial adhesin F11
Target species:
-
Chicken (broiler)
-
Chicken (for reproduction)
Route of administration:
-
Subcutaneous use
-
Intramuscular use
Product details
Active substance and strength:
-
Escherichia coli, flagellar toxin100.00/microgram(s)0.50millilitre(s)
-
Escherichia coli, fimbrial adhesin F11100.00/microgram(s)0.50millilitre(s)
Pharmaceutical form:
-
Emulsion for injection
Withdrawal period by route of administration:
-
Subcutaneous use
-
Chicken (broiler)
-
Meat and offal35day
-
-
Chicken (for reproduction)
-
Egg0day
-
-
-
Intramuscular use
-
Chicken (broiler)
-
Meat and offal35day
-
-
Chicken (for reproduction)
-
Egg0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01AB05
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Cyprus
Package description:
- Available only in Greek
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - new active substance (Article 8 of Regulation (EU) 2019/6)
Marketing authorisation holder:
- Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Intervet International B.V.
Responsible authority:
- Veterinary Services, Ministry Of Agriculture, Natural Resources And Environment
Authorisation number:
- 17078
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 4/11/2025